太阳花
Lv5
1340 积分
2021-07-24 加入
-
Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients
3天前
已完结
-
CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study
10天前
已完结
-
Emerging Strategies for the Treatment of Small Cell Lung Cancer
29天前
已完结
-
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)
1个月前
已完结
-
Characteristics, treatment patterns and outcomes of patients with small cell lung cancer—A retrospective single institution analysis
1个月前
已完结
-
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
1个月前
已完结
-
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
1个月前
已完结
-
Lenalidomide: A Review in Previously Treated Follicular Lymphoma
1个月前
已完结
-
Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non‐Hodgkin lymphoma
1个月前
已完结